These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1706610)

  • 1. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives).
    Coiffier B; Brousse N; Peuchmaur M; Berger F; Gisselbrecht C; Bryon PA; Diebold J
    Ann Oncol; 1990; 1(1):45-50. PubMed ID: 1706610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
    Morel P; Dupriez B; Herbrecht R; Bastion Y; Tilly H; Delannoy A; Haioun C; Nouvel C; Bouabdallah K; Baumelou E
    Br J Cancer; 1994 Jul; 70(1):154-9. PubMed ID: 7517172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs.
    Salles G; Herbrecht R; Tilly H; Berger F; Brousse N; Gisselbrecht C; Coiffier B
    Am J Med; 1991 Jan; 90(1):77-84. PubMed ID: 1702581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
    Coiffier B; Gisselbrecht C; Vose JM; Tilly H; Herbrecht R; Bosly A; Armitage JO
    J Clin Oncol; 1991 Feb; 9(2):211-9. PubMed ID: 1703226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: the Stanford experience.
    Kwak LW; Wilson M; Weiss LM; Doggett R; Dorfman RF; Warnke RA; Horning SJ
    J Clin Oncol; 1991 Aug; 9(8):1426-31. PubMed ID: 1712837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best treatment of aggressive non-Hodgkin's lymphoma: a French perspective.
    Coiffier B; Reyes F;
    Oncology (Williston Park); 2005 Apr; 19(4 Suppl 1):7-15. PubMed ID: 15934513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.
    Brice P; Cazals D; Mounier N; Verola O; Neidhart-Berard AM; Remenieras L; Deconinck E; Doyen C; Hamelsand J; Molina T; Moulonguet I; Gisselbrecht C
    Leukemia; 1998 Feb; 12(2):213-9. PubMed ID: 9519784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Hermine O; Haioun C; Lepage E; d'Agay MF; Briere J; Lavignac C; Fillet G; Salles G; Marolleau JP; Diebold J; Reyas F; Gaulard P
    Blood; 1996 Jan; 87(1):265-72. PubMed ID: 8547651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma.
    Binn M; Ruskoné-Fourmestraux A; Lepage E; Haioun C; Delmer A; Aegerter P; Lavergne A; Guettier C; Delchier JC
    Ann Oncol; 2003 Dec; 14(12):1751-7. PubMed ID: 14630680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).
    Lepage E; Gisselbrecht C; Haioun C; Sebban C; Tilly H; Bosly A; Morel P; Herbrecht R; Reyes F; Coiffier B
    Ann Oncol; 1993 Sep; 4(8):651-6. PubMed ID: 7694634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.
    Besson C; Canioni D; Lepage E; Pol S; Morel P; Lederlin P; Van Hoof A; Tilly H; Gaulard P; Coiffier B; Gisselbrecht C; Brousse N; Reyes F; Hermine O;
    J Clin Oncol; 2006 Feb; 24(6):953-60. PubMed ID: 16418500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term results with MACOP-B and radiation therapy for aggressive lymphomas].
    Krieger G; Kreysing E; Kneba M
    Onkologie; 2001 Feb; 24 Suppl 1():49-58. PubMed ID: 11441311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.
    Diviné M; Lepage E; Brière J; Pautier P; Dupriez B; Lederlin P; Mineur P; Tilly H; Blanc M; Audhuy B; Herbrecht R; Coiffier B; Reyes F
    J Clin Oncol; 1996 Jan; 14(1):240-8. PubMed ID: 8558204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study.
    Cazals-Hatem D; Lepage E; Brice P; Ferrant A; d'Agay MF; Baumelou E; Brière J; Blanc M; Gaulard P; Biron P; Schlaifer D; Diebold J; Audouin J
    Am J Surg Pathol; 1996 Jul; 20(7):877-88. PubMed ID: 8669537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
    Mourad N; Mounier N; Brière J; Raffoux E; Delmer A; Feller A; Meijer CJ; Emile JF; Bouabdallah R; Bosly A; Diebold J; Haioun C; Coiffier B; Gisselbrecht C; Gaulard P;
    Blood; 2008 May; 111(9):4463-70. PubMed ID: 18292286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2.
    Morel P; Gaulard P; Gisselbrecht C; Ferme C; Salles G; Tilly H; Brière J; Copin MC; Lederlin P; Hermine O; Theate I; Haioun C; Mounier N;
    Ann Oncol; 2008 Mar; 19(3):560-5. PubMed ID: 18096567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive non-Hodgkin's lymphoma: T-cell versus B-cell.
    Liang R; Todd D; Ho FC
    Hematol Oncol; 1996 Mar; 14(1):1-6. PubMed ID: 8613131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomas.
    Karakas T; Bergmann L; Stutte HJ; Jäger E; Knuth A; Weidmann E; Mitrou PS; Hoelzer D
    Leuk Lymphoma; 1996 Dec; 24(1-2):121-9. PubMed ID: 9049968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct comparison of peripheral T-cell lymphomas with their B-cell counterpart.
    Liang R; Chiu E; Chan TK; Todd D; Loke SL
    Acta Haematol; 1991; 85(4):179-83. PubMed ID: 1713011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
    Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.